Key statistics
On Monday, Olema Pharmaceuticals Inc (OLMA:NSQ) closed at 4.83, 68.88% above the 52 week low of 2.86 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.62 |
---|---|
High | 4.86 |
Low | 4.61 |
Bid | 4.49 |
Offer | 5.04 |
Previous close | 4.65 |
Average volume | 425.63k |
---|---|
Shares outstanding | 68.42m |
Free float | 55.20m |
P/E (TTM) | -- |
Market cap | 318.16m USD |
EPS (TTM) | -1.94 USD |
Data delayed at least 15 minutes, as of Jul 14 2025 21:00 BST.
More ▼
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
- Olema Oncology to Participate in Upcoming Investor Conferences
- Olema Oncology Reports First Quarter 2025 Financial and Operating Results
- Olema Oncology to Participate in Upcoming Investor Conferences
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting
More ▼